CMIC’s Hong Kong office was established in 2015 to provide full operational services in the execution of clinical trials under the Pharmaceutical Value Creator (PVC) model. With more than 4 years’ experience in Hong Kong for projects of global and local scales, we understand the region’s biopharmaceutical and healthcare markets.
Our combination of industry experience and expertise across a broad spectrum of therapeutic areas and phases can help you accelerate clinical and commercial success to deliver better medicines, sooner.
Hong Kong is densely populated, allowing for a fewer number of sites to be setup. The country also has a developed infrastructure with a strong presence of academic institutions, but this also causes competition between trials. CMIC is connected to multiple sites in order to best identify qualifying sites for each trial’s unique traits.
Regulatory consultation and dossier submission to health authorities (HA) and ethics committees (EC)
Clinical monitoring and site management
Full Biometrics support and Clinical Study Report (CSR) writing
Pharmacovigilance and medical monitoring
Quality assurance and quality compliance services
Facility Contact Information
Unit C, 4/F, China Insurance Building, 48 Cameron Road, Tsim Sha Tsui, Kowloon, Hong Kong
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.